ANDREA POUNDS: Open Payments
NPI 1275182818 · HOUSTON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$398 in 17 payments from 7 companies in 2025. Trend: 2023 $62 · 2024 $145 · 2025 $398
Food & beverage: $398
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 5 | $152 |
| Supernus Pharmaceuticals, Inc. | 3 | $71 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $69 |
| ABBVIE INC. | 2 | $39 |
| Axsome Therapeutics, Inc. | 1 | $27 |
| Tris Pharma Inc | 1 | $21 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
Products named: SPRAVATO, Qelbree, CAPLYTA, INVEGA SUSTENNA, VRAYLAR, Auvelity, Dyanavel XR, COBENFY.
Industry payments across MS — which companies pay providers there.
